PeptidePedia The community reference

Contributions of ProglucagonPia

User contributions·27 logged edits·page 1 of 1

Contributions by ProglucagonPia, newest first. This list covers edits recorded in the site's change log; the editor's lifetime total of 2,922 edits includes activity predating the current log.

  1. 06:10, 10 Jun 2026 (diff | hist) Insulin secretion 6,940 ±0 attribute the receptor-density claim to the tissue study it comes from
  2. 11:15, 17 Feb 2026 (diff | hist) Talk:Survodutide 674 +162 /* Oxyntomodulin as template */ new section
  3. 08:15, 12 Feb 2026 (diff | hist) Talk:Proglucagon 822 +60 /* Islet-derived GLP-1: how much weight to give it? */ reply
  4. 09:50, 11 Feb 2026 (diff | hist) Talk:Proglucagon 400 +223 /* Islet-derived GLP-1: how much weight to give it? */ new section
  5. 18:19, 17 Dec 2025 (diff | hist) Enteroendocrine L cell 5,083 ±0 expand §L-cell plasticity and regulation
  6. 18:50, 6 Dec 2025 (diff | hist) Beta cell function 6,096 ±0 convert the receptor-distribution list to a table
  7. 10:02, 30 Nov 2025 (diff | hist) GLP-1 receptor 7,570 ±0 m add the postprandial time course with its units
  8. 09:43, 19 Nov 2025 (diff | hist) Albumin binding half-life extension 6,399 ±0 split overlong sentence
  9. 07:59, 2 Nov 2025 (diff | hist) Dipeptidyl peptidase-4 7,022 ±0 split §Physiology from §Pharmacological exploitation
  10. 20:50, 12 Sep 2025 (diff | hist) Glucagon-like peptide-1 12,102 ±0 m the article treated a rodent finding as human physiology; corrected
  11. 11:13, 10 Jun 2025 (diff | hist) Test report forgery 4,203 ±0 split §What a report shows from §What it does not
  12. 08:02, 21 May 2025 (diff | hist) Glucose-dependent insulinotropic polypeptide 6,898 +187 expand §Therapeutic exploitation
  13. 06:22, 14 May 2025 (diff | hist) Missed dose 4,989 +582 convert the conversion list to a table so the three syringe scales align
  14. 19:25, 2 May 2025 (diff | hist) TRIUMPH trial programme 4,014 ±0 ce per PP:MOS
  15. 17:16, 6 Apr 2025 (diff | hist) Insulin secretion 5,442 ±0 alphabetise the see-also list
  16. 19:27, 26 Mar 2025 (diff | hist) Satiety signalling 4,441 ±0 expand §Central integration
  17. 16:11, 18 Feb 2025 (diff | hist) Albumin binding half-life extension 4,872 +361 m the article treated a rodent finding as human physiology; corrected
  18. 18:12, 1 Feb 2025 (diff | hist) Arcuate nucleus 3,874 +101 rm the causal claim about appetite — the cited work is associative
  19. 06:52, 20 Dec 2024 (diff | hist) Satiety signalling 3,974 +36 m close an unbalanced quotation mark
  20. 22:46, 3 Dec 2024 (diff | hist) HOMA-IR 2,497 +180 m correct the decimal place in the conversion factor
  21. 21:21, 5 Nov 2024 (diff | hist) Bachem Holding (Suzhou) 3,335 +1,232 expand §Regulatory position and legal status
  22. 20:28, 9 Oct 2024 (diff | hist) Receptor bias 2,105 +167 m give the fasting and postprandial concentrations with the assay named
  23. 20:08, 15 Aug 2024 (diff | hist) Glucagon-like peptide-1 5,430 +569 m add the reference range with the assay it was established on
  24. 16:52, 1 Aug 2024 (diff | hist) Gastric emptying 1,386 +1,386 N new article: incretin physiology, expansion welcome
  25. 20:06, 17 Jul 2024 (diff | hist) Incretin effect 2,353 ±0 clarify that the incretin effect is defined by the oral–intravenous comparison
  26. 23:11, 7 Jul 2024 (diff | hist) Incretin effect 2,353 +512 rm the sentence implying the hormone is a drug
  27. 09:00, 22 Jun 2024 (diff | hist) Dipeptidyl peptidase-4 2,323 +2,323 N create article — physiology stub